Intensive Inpatient BP Management Not Beneficial in Seniors
Risk for adverse events increased with intensive treatment among older adults with elevated BP in first 48 hours of hospitalization
Diagnosis & Disease Information
Statins Increase Risk of Diabetes, Cataracts in Kidney Transplant Recipients
Statins are the third most prescribed drug class in kidney transplant recipients due to the high incidence of cardiovascular disease.
Hyperkalemia Risk Varies by Antihypertensive Combo for Diabetic Kidney Disease
Antihypertensive regimens that include a mineralocorticoid receptor antagonist carry the highest risk for hyperkalemia.
Update on Bladder Cancer Risk Factors
Emerging evidence links bladder cancer to pelvic radiation therapy, dietary factors, and gene-environment interactions.
Second-Generation Antiandrogens Up Risk for Cognitive, Functional Toxic Effects
The increasing number of indications for second-generation antiandrogens may result in a large group of men at risk for toxic effects, according to investigators.
Real-World mCSPC First-Line Treatment Intensification Remains Low
Study findings highlight the need for earlier mCSPC treatment intensification by urologists and oncologists.
Race Disparity Found in Overactive Bladder Medication Prescriptions
The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB.
Antibiotic-Related Sudden Cardiac Death Linked to Dialysis Potassium Gradient
The risks for sudden cardiac death from certain QT-prolonging antibiotics increase with steeper serum to dialysate potassium gradients.
Higher Tacrolimus Trough Levels May Reduce Early Acute Rejection Risk
Monitoring and maintaining a higher tacrolimus trough level in the first month after transplantation is essential to avoid acute rejection, according to investigators.
Adding ADT to Radiation Does Not Up Survival in Intermediate-Risk Prostate Cancer
NRG 0815 is a “landmark” study investigating the role of short-term androgen deprivation therapy added to modern, dose-escalated radiation to treat intermediate-risk prostate cancer.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...